List of articles with "Neurocrine Biosciences"

Neurocrine's Review on INGREZZA

Neurocrine's Review on INGREZZA

USA San Diego Neurocrine Biosciences INGREZZA VMAT2 Inhibitors
NBI-1070770 Study Update

NBI-1070770 Study Update

United States San Diego MDD Neurocrine Biosciences NBI-1070770
Neurocrine Q3 2025 Results

Neurocrine Q3 2025 Results

USA San Diego Crenessity Neurocrine Biosciences INGREZZA
Mike Sibley Joins Neurocrine

Mike Sibley Joins Neurocrine

USA San Diego Neurocrine Biosciences INGREZZA Mike Sibley
Long-Term INGREZZA Efficacy

Long-Term INGREZZA Efficacy

USA Honolulu Huntington's Disease Neurocrine Biosciences INGREZZA
Neurocrine's Osavampator Data

Neurocrine's Osavampator Data

United States San Diego Neurocrine Biosciences Osavampator SAVITRI
Neurocrine's September Events

Neurocrine's September Events

United States San Diego Healthcare Conference Investor Relations Neurocrine Biosciences
Neurocrine Q2 Results

Neurocrine Q2 Results

United States San Diego Crenessity Neurocrine Biosciences INGREZZA
Innovative Care Solutions

Innovative Care Solutions

United States San Francisco CAH Neurocrine Biosciences PICNICH
Neurocrine at ENDO 2025

Neurocrine at ENDO 2025

United States San Francisco Neurocrine Biosciences Congenital Adrenal Hyperplasia CAHtalog
Neurocrine at ENDO 2025

Neurocrine at ENDO 2025

United States San Francisco Crenessity Neurocrine Biosciences CAHtalyst
Neurocrine's Phase 1 Study

Neurocrine's Phase 1 Study

USA San Diego CAH Neurocrine Biosciences NBIP-01435
Neurocrine Appoints CIO

Neurocrine Appoints CIO

United States San Diego Neurocrine Biosciences INGREZZA Lewis Choi
Positive NBI-1117568 Data

Positive NBI-1117568 Data

United States Scottsdale schizophrenia Neurocrine Biosciences NBI-1117568
Neurocrine Study on TD

Neurocrine Study on TD

USA San Diego Neurocrine Biosciences INGREZZA Tardive Dyskinesia
Neurocrine at PES 2025

Neurocrine at PES 2025

United States National Harbor Crenessity Neurocrine Biosciences CAHtalyst Study
CRENESSITY Insights Revealed

CRENESSITY Insights Revealed

San Diego Crenessity CAH Neurocrine Biosciences
New CAH Treatment Findings

New CAH Treatment Findings

USA San Diego Crenessity Neurocrine Biosciences CAHtalyst
Neurocrine's Conferences

Neurocrine's Conferences

United States healthcare Investor Conferences Neurocrine Biosciences Las Vegas, New York
Tardive Dyskinesia Campaign

Tardive Dyskinesia Campaign

USA San Diego Neurocrine Biosciences Tardive Dyskinesia Carnie Wilson
Neurocrine Q1 2025 Results

Neurocrine Q1 2025 Results

USA San Diego Crenessity Neurocrine Biosciences INGREZZA
Survey on Tardive Dyskinesia

Survey on Tardive Dyskinesia

United States San Diego Neurocrine Biosciences Tardive Dyskinesia Awaremess Week
NBI-1117568 Phase 3 Study

NBI-1117568 Phase 3 Study

United States San Diego schizophrenia Neurocrine Biosciences NBI-1117568
INGREZZA® Efficacy Analysis

INGREZZA® Efficacy Analysis

United States San Diego Neurocrine Biosciences INGREZZA Tardive Dyskinesia
INGREZZA and Chorea

INGREZZA and Chorea

United States San Diego Huntington's Disease Neurocrine Biosciences INGREZZA
Neurocrine at CNS Forum

Neurocrine at CNS Forum

United States San Diego Neurocrine Biosciences Neuroscience CNS Forum
Neurocrine Phase 1 Study

Neurocrine Phase 1 Study

United States San Diego Neurocrine Biosciences NBI-1140675 VMAT2 Inhibitor
Neurocrine Study Results

Neurocrine Study Results

United States San Diego Neurocrine Biosciences INGREZZA Tardive Dyskinesia
Neurocrine Financial Results

Neurocrine Financial Results

United States San Diego Crenessity Neurocrine Biosciences INGREZZA
New CAH Research Published

New CAH Research Published

USA San Diego Crenessity CAH Neurocrine Biosciences
CRENESSITY™ FDA Approval

CRENESSITY™ FDA Approval

USA San Diego Crenessity CAH Neurocrine Biosciences

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.